Patents by Inventor William Philbrick

William Philbrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11795781
    Abstract: A tool, e.g. a downhole tool, utilizes at least one actuator which may be actuated rapidly between positions during operation of the tool. The actuator is moved via flow of an actuating fluid controlled by a main valve which, in turn, is controlled via a pilot valve. The pilot valve is operated to selectively control flow of the actuating fluid to the main valve so as to shift the main valve between desired operational positions.
    Type: Grant
    Filed: March 11, 2021
    Date of Patent: October 24, 2023
    Assignee: SCHLUMBERGER TECHNOLOGY CORPORATION
    Inventors: Edward George Parkin, Michael Pearce, Julien Steimetz, Jonathan D. Marshall, D. Peter Johnson, Clint William Philbrick
  • Publication number: 20230142360
    Abstract: A torsional damping system includes a housing having an interior space. An inertia ring is located in the interior space, and a torsion fluid is located between the inertia ring and the housing. The inertia ring is rotatably installed relative to the housing. As the housing oscillates, the inertia ring damps at least a portion of the oscillation. The torsional damping system may be included in a downhole tool or bottomhole assembly, and used to damp oscillations along a drill string or along the bottomhole assembly, including between a downhole motor and a cutting tool.
    Type: Application
    Filed: March 30, 2021
    Publication date: May 11, 2023
    Inventors: Yuelin Shen, Mauro Caresta, Scott Richard Woolston, Clint William Philbrick
  • Publication number: 20210198977
    Abstract: A tool, e.g. a downhole tool, utilizes at least one actuator which may be actuated rapidly between positions during operation of the tool. The actuator is moved via flow of an actuating fluid controlled by a main valve which, in turn, is controlled via a pilot valve. The pilot valve is operated to selectively control flow of the actuating fluid to the main valve so as to shift the main valve between desired operational positions.
    Type: Application
    Filed: March 11, 2021
    Publication date: July 1, 2021
    Inventors: Edward George Parkin, Michael Pearce, Julien Steimetz, Jonathan D. Marshall, D. Peter Johnson, Clint William Philbrick
  • Patent number: 10947814
    Abstract: A tool, e.g. a downhole tool, utilizes at least one actuator which may be actuated rapidly between positions during operation of the tool. The actuator is moved via flow of an actuating fluid controlled by a main valve which, in turn, is controlled via a pilot valve. The pilot valve is operated to selectively control flow of the actuating fluid to the main valve so as to shift the main valve between desired operational positions.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: March 16, 2021
    Assignee: SCHLUMBERGER TECHNOLOGY CORPORATION
    Inventors: Edward George Parkin, Michael Pearce, Julien Steimetz, Jonathan D. Marshall, D. Peter Johnson, Clint William Philbrick
  • Publication number: 20200063526
    Abstract: A tool, e.g. a downhole tool, utilizes at least one actuator which may be actuated rapidly between positions during operation of the tool. The actuator is moved via flow of an actuating fluid controlled by a main valve which, in turn, is controlled via a pilot valve. The pilot valve is operated to selectively control flow of the actuating fluid to the main valve so as to shift the main valve between desired operational positions.
    Type: Application
    Filed: August 22, 2018
    Publication date: February 27, 2020
    Inventors: Edward George Parkin, Michael Pearce, Julien Steimetz, Jonathan D. Marshall, D. Peter Johnson, Clint William Philbrick
  • Patent number: 9839208
    Abstract: The invention relates generally to compositions and methods of using transgenic non-human animals expressing human SIRP? that are engrafted with a human hematopoietic system. In various embodiments, the human hematopoietic system engrafted, human SIRP? transgenic non-human animals of the invention are useful as systems for the in vivo evaluation of the growth and differentiation of hematopoietic and immune cells, for the in vivo assessment of an immune response, for the in vivo evaluation of vaccines and vaccination regimens, for in vivo production and collection of immune mediators, including human antibodies, and for use in testing the effect of agents that modulate hematopoietic and immune cell function.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: December 12, 2017
    Assignee: YALE UNIVERSITY
    Inventors: Richard A. Flavell, Till Strowig, Elizabeth Eynon, William Philbrick, Markus Manz
  • Publication number: 20170027140
    Abstract: The invention relates generally to compositions and methods of using transgenic non-human animals expressing human SIRP? that are engrafted with a human hematopoietic system. In various embodiments, the human hematopoietic system engrafted, human SIRP? transgenic non-human animals of the invention are useful as systems for the in vivo evaluation of the growth and differentiation of hematopoietic and immune cells, for the in vivo assessment of an immune response, for the in vivo evaluation of vaccines and vaccination regimens, for in vivo production and collection of immune mediators, including human antibodies, and for use in testing the effect of agents that modulate hematopoietic and immune cell function.
    Type: Application
    Filed: July 29, 2016
    Publication date: February 2, 2017
    Inventors: Richard A. Flavell, Till Strowig, Elizabeth Eynon, William Philbrick, Markus Manz
  • Patent number: 9402377
    Abstract: The invention relates generally to compositions and methods of using transgenic non-human animals expressing human SIRP? that are engrafted with a human hematopoietic system. In various embodiments, the human hematopoietic system engrafted, human SIRP? transgenic non-human animals of the invention are useful as systems for the in vivo evaluation of the growth and differentiation of hematopoietic and immune cells, for the in vivo assessment of an immune response, for the in vivo evaluation of vaccines and vaccination regimens, for in vivo production and collection of immune mediators, including human antibodies, and for use in testing the effect of agents that modulate hematopoietic and immune cell function.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: August 2, 2016
    Assignee: Yale University
    Inventors: Richard A. Flavell, Till Strowig, Elizabeth Eynon, William Philbrick, Markus Manz
  • Publication number: 20130340105
    Abstract: The invention relates generally to compositions and methods of using transgenic non-human animals expressing human SIRP? that are engrafted with a human hematopoietic system. In various embodiments, the human hematopoietic system engrafted, human SIRP? transgenic non-human animals of the invention are useful as systems for the in vivo evaluation of the growth and differentiation of hematopoietic and immune cells, for the in vivo assessment of an immune response, for the in vivo evaluation of vaccines and vaccination regimens, for in vivo production and collection of immune mediators, including human antibodies, and for use in testing the effect of agents that modulate hematopoietic and immune cell function.
    Type: Application
    Filed: September 20, 2011
    Publication date: December 19, 2013
    Applicant: Yale University
    Inventors: Richard A. Flavell, Till Strowig, Elizabeth Eynon, William Philbrick, Markus Manz